Trials / Completed
CompletedNCT01368562
Compassionate Use Study of Methylnaltrexone
A Compassionate Use Study of Methylnaltrexone in Patients With Opioid-Induced Side Effects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label compassionate use study of subcutaneously administered methylnaltrexone (MNTX) in participants with advance medical illness and opioid-induced constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylnaltrexone | Methylnaltrexone will be administered as per the dose and schedule specified in the arm. |
Timeline
- Start date
- 2003-01-24
- Primary completion
- 2008-06-02
- Completion
- 2008-06-02
- First posted
- 2011-06-08
- Last updated
- 2019-09-04
- Results posted
- 2019-09-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01368562. Inclusion in this directory is not an endorsement.